Skip to main content
. 2019 Dec 19;10:5785. doi: 10.1038/s41467-019-13708-y

Fig. 6. Mutant KRAS expression abrogates the progestin-induced anti-proliferative effect of DNG through downregulation of PR.

Fig. 6

a Immunoblotting to detect ectopically expressed, HA-tagged wild-type (WT) KRAS and PIK3CA, or KRAS or PIK3CA bearing the indicated amino acid substitutions, in immortalized human uterine epithelial cells. Vinculin, loading control. Viability (b) and proliferation (c) of WT immortalized uterine endometrial epithelial cells or those overexpressing the indicated mutations of KRAS or PIK3CA. b Cells were exposed to 1 μM DNG or vehicle (DMSO) for 72 h. Results are the percentage of viable cells relative to vehicle control cells. Data are the mean + SD of six independent experiments, each with three technical replicates per group. *p< 0.05 by Welch’s t-test. c Cells were exposed to 1 μM DNG or vehicle (DMSO) for 48 h. Results are the percentage of BrdU+ cells relative to vehicle control cells. Data are the mean + SD of four independent experiments per group without technical replicates. *p< 0.05 by Welch’s t-test. d Quantitative RT–PCR determination of mRNA levels of PR-A/B in the immortalized cells in a. Values were normalized to GAPDH. Data are the mean fold change + SD relative to levels in control cells stably infected with empty vector. Six independent experiments, each with three technical replicates per group, were conducted. *p< 0.05 by Welch’s t-test. Source data are provided as a Source Data file.